VistaGen Therapeutics Inc
0.00 (0.0%)
Company Name Stock Ticker Symbol Market Type
VistaGen Therapeutics Inc VTGN NASDAQ Common Stock
  Price Change Change Percent Stock Price Last Traded
0.00 0.0% 0.14 19:54:55
Open Price Low Price High Price Close Price Prev Close
0.1375 0.131 0.145 0.1389 0.14
more quote information »

Recent News

Date Time Source Heading
3/23/202309:16EDGARCurrent Report Filing (8-k)
3/22/202308:30BWVistagen Announces Positive Data in Fasedienol (PH94B) Phase..
3/22/202306:05EDGARNotice of Effectiveness (effect)
3/17/202316:29EDGARSecurities Registration Statement (simplified Form) (s-3/a)
3/08/202317:34EDGARCurrent Report Filing (8-k)
3/08/202308:30BWVistagen Announces Completion of Last Patient, Last Visit in..
3/02/202316:35EDGARSecurities Registration Statement (simplified Form) (s-3)
3/02/202308:30BWVistagen to Present at Cowen 43rd Annual Health Care..
3/02/202306:28EDGARCurrent Report Filing (8-k)
3/01/202308:30BWVistagen Announces Issuance of U.S. Patent for PH80 Nasal..
2/21/202306:01EDGARSmall Company Offering and Sale of Securities Without..
2/14/202317:38EDGARAmended Statement of Ownership (sc 13g/a)
2/14/202316:11EDGARAmended Statement of Ownership (sc 13g/a)
2/14/202315:33EDGARAmended Statement of Ownership (sc 13g/a)
2/07/202316:30EDGARCurrent Report Filing (8-k)
2/07/202316:20BWVistagen Provides Corporate Update and Reports Fiscal 2023..
2/07/202316:17EDGARQuarterly Report (10-q)
2/06/202309:09BWVistagen to Report Fiscal Year 2023 Third Quarter Financial..
2/02/202309:11EDGARCurrent Report Filing (8-k)
2/02/202309:00BWVistagen Announces Closing of Pherin Pharmaceuticals..
2/01/202313:50EDGARAmended Statement of Ownership (sc 13g/a)
1/25/202306:01EDGARCurrent Report Filing (8-k)
1/24/202308:30BWVistagen Announces First Participants Dosed in Phase 1..
1/12/202306:29EDGARCurrent Report Filing (8-k)
1/10/202308:30BWVistagen Announces Completion of Last Patient, Last Visit in..
1/03/202316:12EDGARStatement of Changes in Beneficial Ownership (4)
1/03/202316:11EDGARStatement of Changes in Beneficial Ownership (4)
12/30/202208:30BWVistagen Advances Intellectual Property Program to Expand..
12/21/202208:31EDGARCurrent Report Filing (8-k)
12/21/202208:30BWVistagen to Acquire Pherin Pharmaceuticals
12/16/202208:35GLOBEKCSA Mental Health Virtual Investor Conference:..
12/13/202208:35GLOBEKCSA Mental Health Virtual Investor Conference Agenda..
12/07/202212:05TRMNMaxim Group Sticks to Its Hold Rating for VistaGen..
12/06/202216:17EDGARCurrent Report Filing (8-k)
12/06/202208:30BWVistagen Receives FDA Fast Track Designation for Development..
12/01/202206:05EDGARCurrent Report Filing (8-k)
11/30/202208:30BWVistagen Receives FDA “Study May Proceed” Letter Under its..
11/23/202206:02EDGARCurrent Report Filing (8-k)
11/22/202206:02EDGARCurrent Report Filing (8-k)
11/17/202208:30BWVistagen Announces Publication in Cells Demonstrating..
11/13/202222:46TRMNRobert W. Baird Reaffirms Their Hold Rating on VistaGen..
11/12/202209:15TRMNMaxim Group Sticks to Its Hold Rating for VistaGen..
11/10/202216:43EDGARCurrent Report Filing (8-k)
11/10/202216:30BWVistagen Reports Second Quarter Financial Results and..
11/10/202216:26EDGARQuarterly Report (10-q)
11/04/202208:30BWVistagen to Report Fiscal Year 2023 Second Quarter Financial..
11/03/202208:30BWVistagen to Present at Stifel 2022 Healthcare Conference
10/26/202209:00BWVistagen to Host Concordia Live Webinar on Mental Health..
10/19/202216:30BWVistagen Announces Results of Voting from 2022 Annual..
10/06/202217:16EDGARCurrent Report Filing (8-k)